Genmab has a total of 1776 patents globally, out of which 555 have been granted. Of these 1776 patents, more than 77% patents are active. The USA is where Genmab has filed the maximum number of patents, followed by Japan and European Countries, it has generated an annual revenue of $1.34 billion in the year 2021. Parallelly, Denmark seems to be the main focused R&D centre of Genmab.
Genmab was founded in the year 1999 Florian Schönharting and Lisa Drakeman. Genmab operates as a biotechnology company and specializes in development of antibody therapeutics for the treatment of cancer. Genmab serves customers worldwide. As of July 2022, Genmab has a market cap of $22.35 Billion.
Do read about some of the most popular patents of Genmab which have been covered by us in this article and also you can find Genmab patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Genmab patent portfolio.
How many patents does the founder and the CEO of Genmab have?
The founders, Florian Schönharting and Lisa Drakeman, have 31 and 0 patents respectively. The CEO, Jan van de Winkel, has 90 patents.
How many patents does Genmab have?
Genmab has a total of 1776 patents globally. These patents belong to 375 unique patent families. Out of 1776 patents, 1372 patents are active.
How Many Patents did Genmab File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Genmab Applications Filed | Genmab Patents Granted |
| 2011 | 116 | 16 |
| 2012 | 107 | 27 |
| 2013 | 63 | 13 |
| 2014 | 75 | 29 |
| 2015 | 61 | 32 |
| 2016 | 153 | 30 |
| 2017 | 107 | 57 |
| 2018 | 89 | 39 |
| 2019 | 242 | 92 |
| 2020 | 121 | 90 |
| 2021 | 112 | 48 |
| 2022 | 20 | 28 |
How many Genmab patents are Alive/Dead?
How Many Patents did Genmab File in Different Countries?
Countries in which Genmab Filed Patents
| Country | Patents |
| United States Of America | 229 |
| Japan | 208 |
| Europe | 125 |
| Australia | 107 |
| Korea (South) | 96 |
| Hong Kong (S.A.R.) | 93 |
| Singapore | 69 |
| Canada | 68 |
| India | 66 |
| Israel | 62 |
| Germany | 50 |
| Brazil | 47 |
| Mexico | 46 |
| China | 43 |
| New Zealand | 40 |
| Eurasia | 34 |
| Spain | 30 |
| Denmark | 22 |
| Hungary | 21 |
| Poland | 20 |
| Portugal | 20 |
| Lithuania | 18 |
| Slovenia | 16 |
| Serbia | 13 |
| South Africa | 12 |
| Montenegro | 11 |
| Croatia | 10 |
| Taiwan | 9 |
| Albania | 9 |
| Indonesia | 7 |
| Austria | 6 |
| Philippines | 6 |
| Cyprus | 6 |
| Ukraine | 5 |
| Russia | 5 |
| Argentina | 4 |
| Turkey | 3 |
| Peru | 3 |
| Costa Rica | 2 |
| Luxembourg | 2 |
| Norway | 2 |
| Viet Nam | 2 |
| Panama | 2 |
| Chile | 2 |
| Malaysia | 2 |
| Czech Republic | 1 |
| Dominican Republic | 1 |
| United Kingdom | 1 |
Where are Research Centres of Genmab Patents Located?
10 Best Genmab Patents
US7153507B2 is the most popular patent in the Genmab portfolio. It has received 451 citations so far from companies like Amgen, Abbvie Biotechnology, and Innate Pharma.
Below is the list of 10 most cited patents of Genmab:
| Publication Number | Citation Count |
| US7153507B2 | 451 |
| WO2008145142A1 | 285 |
| US7247301B2 | 239 |
| US20040255137A1 | 159 |
| US20060161789A1 | 127 |
| WO2011154453A1 | 119 |
| US7829673B2 | 110 |
| WO2012143523A1 | 109 |
| WO2004058797A2 | 108 |
| WO2011147986A1 | 105 |
EXCLUSIVE INSIGHTS COMING SOON!
What are Genmab’s key innovation segments?
What Technologies are Covered by Genmab?
The chart below distributes patents filed by Genmab in different countries on the basis of the technology protected in patents. It also represents the markets where Genmab thinks it’s important to protect particular technology inventions.
R&D Focus: How Genmab’s search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by Genmab?
